400 related articles for article (PubMed ID: 24830937)
1. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial.
Rodríguez-Moran M; Guerrero-Romero F
Arch Med Res; 2014 Jul; 45(5):388-93. PubMed ID: 24830937
[TBL] [Abstract][Full Text] [Related]
2. Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study.
Toprak O; Kurt H; Sarı Y; Şarkış C; Us H; Kırık A
Kidney Blood Press Res; 2017; 42(1):33-42. PubMed ID: 28297698
[TBL] [Abstract][Full Text] [Related]
3. Oral Magnesium Supplementation and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Rodríguez-Morán M; Simental-Mendía LE; Gamboa-Gómez CI; Guerrero-Romero F
Adv Chronic Kidney Dis; 2018 May; 25(3):261-266. PubMed ID: 29793665
[TBL] [Abstract][Full Text] [Related]
4. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial.
Guerrero-Romero F; Simental-Mendía LE; Hernández-Ronquillo G; Rodriguez-Morán M
Diabetes Metab; 2015 Jun; 41(3):202-7. PubMed ID: 25937055
[TBL] [Abstract][Full Text] [Related]
5. Serum magnesium in the metabolically-obese normal-weight and healthy-obese subjects.
Guerrero-Romero F; Rodriguez-Moran M
Eur J Intern Med; 2013 Oct; 24(7):639-43. PubMed ID: 23523313
[TBL] [Abstract][Full Text] [Related]
6. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial.
Rodríguez-Morán M; Guerrero-Romero F
Diabetes Care; 2003 Apr; 26(4):1147-52. PubMed ID: 12663588
[TBL] [Abstract][Full Text] [Related]
7. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial.
Guerrero-Romero F; Tamez-Perez HE; González-González G; Salinas-Martínez AM; Montes-Villarreal J; Treviño-Ortiz JH; Rodríguez-Morán M
Diabetes Metab; 2004 Jun; 30(3):253-8. PubMed ID: 15223977
[TBL] [Abstract][Full Text] [Related]
8. Oral magnesium supplementation decreases C-reactive protein levels in subjects with prediabetes and hypomagnesemia: a clinical randomized double-blind placebo-controlled trial.
Simental-Mendía LE; Rodríguez-Morán M; Guerrero-Romero F
Arch Med Res; 2014 May; 45(4):325-30. PubMed ID: 24814039
[TBL] [Abstract][Full Text] [Related]
9. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial.
Mooren FC; Krüger K; Völker K; Golf SW; Wadepuhl M; Kraus A
Diabetes Obes Metab; 2011 Mar; 13(3):281-4. PubMed ID: 21205110
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of oral magnesium supplementation in the treatment of depression in the elderly with type 2 diabetes: a randomized, equivalent trial.
Barragán-Rodríguez L; Rodríguez-Morán M; Guerrero-Romero F
Magnes Res; 2008 Dec; 21(4):218-23. PubMed ID: 19271419
[TBL] [Abstract][Full Text] [Related]
11. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial.
Guerrero-Romero F; Rodríguez-Morán M
J Hum Hypertens; 2009 Apr; 23(4):245-51. PubMed ID: 19020533
[TBL] [Abstract][Full Text] [Related]
12. The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial.
Van Laecke S; Nagler EV; Taes Y; Van Biesen W; Peeters P; Vanholder R
Transpl Int; 2014 Sep; 27(9):895-902. PubMed ID: 24909487
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety profile of fenofibrate-coated microgranules 130 mg, with and without food, in patients with hypertriglyceridemia and the metabolic syndrome: an 8-week, randomized, double-blind, placebo-controlled study.
Davidson MH; Bays H; Rhyne J; Stein E; Rotenberg K; Doyle R
Clin Ther; 2005 Jun; 27(6):715-27. PubMed ID: 16117978
[TBL] [Abstract][Full Text] [Related]
14. Zinc supplementation and the effects on metabolic status in gestational diabetes: A randomized, double-blind, placebo-controlled trial.
Karamali M; Heidarzadeh Z; Seifati SM; Samimi M; Tabassi Z; Hajijafari M; Asemi Z; Esmaillzadeh A
J Diabetes Complications; 2015; 29(8):1314-9. PubMed ID: 26233572
[TBL] [Abstract][Full Text] [Related]
15. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
[TBL] [Abstract][Full Text] [Related]
16. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.
Chen CH; Huang MC; Kao CF; Lin SK; Kuo PH; Chiu CC; Lu ML
J Clin Psychiatry; 2013 May; 74(5):e424-30. PubMed ID: 23759461
[TBL] [Abstract][Full Text] [Related]
17. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.
Wilding J; Van Gaal L; Rissanen A; Vercruysse F; Fitchet M;
Int J Obes Relat Metab Disord; 2004 Nov; 28(11):1399-410. PubMed ID: 15486569
[TBL] [Abstract][Full Text] [Related]
18. Magnesium Supplementation and the Effects on Wound Healing and Metabolic Status in Patients with Diabetic Foot Ulcer: a Randomized, Double-Blind, Placebo-Controlled Trial.
Razzaghi R; Pidar F; Momen-Heravi M; Bahmani F; Akbari H; Asemi Z
Biol Trace Elem Res; 2018 Feb; 181(2):207-215. PubMed ID: 28540570
[TBL] [Abstract][Full Text] [Related]
19. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Song Y; He K; Levitan EB; Manson JE; Liu S
Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
[TBL] [Abstract][Full Text] [Related]
20. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
